Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Radical-scavenging furan nitrone compounds in the pipeline at Centaur

April 14, 1998

Adenosine antagonists for CNS, cardiovascular and other disorders

April 14, 1998

Interneuron receives fast track designation for CerAxon

April 9, 1998

MS&D describes novel class of antimigraine agents

April 9, 1998

Advisory committee meeting cancellation announced

April 8, 1998

Abbott discovers new agents for controlling synaptic transmission

April 8, 1998

Study shows Quadramet provides significant relief from bone pain

April 8, 1998

Warner-Lambert announces collaboration with Forest

April 8, 1998

Neurokinin A: a peptide with a potential role in the perception of pain

April 8, 1998

Pfizer NK1 antagonist and ondansetron provide synergistic antiemetic efficacy in clinical trials

April 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.